Cargando…

Natural Antibodies and Alloreactive T Cells Long after Kidney Transplantation

BACKGROUND: The relationship between circulating effector memory T and B cells long after transplantation and their susceptibility to immunosuppression are unknown. To investigate the impact of antirejection therapy on T cell-B cell coordinated immune responses, we assessed IFN-γ-producing memory ce...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Besouw, Nicole M., Rojas, Aleixandra Mendoza, See, Sarah B., de Kuiper, Ronella, Dieterich, Marjolein, Roelen, Dave L., Clahsen-van Groningen, Marian C., Hesselink, Dennis A., Zorn, Emmanuel, Baan, Carla C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8497134/ https://www.ncbi.nlm.nih.gov/pubmed/34631160 http://dx.doi.org/10.1155/2021/7005080

Ejemplares similares

Alloreactive T cells to Assess Acute Rejection Risk in Kidney Transplant Recipients
por: Mendoza Rojas, Aleixandra, et al.
Publicado: (2023)

Pre-transplant donor-reactive IL-21 producing T cells as a tool to identify an increased risk for acute rejection
por: Mendoza Rojas, Aleixandra, et al.
Publicado: (2021)

Immunosuppression Has Long-Lasting Effects on Circulating Follicular Regulatory T Cells in Kidney Transplant Recipients
por: Niu, Qian, et al.
Publicado: (2020)

High Tacrolimus Intrapatient Variability and Subtherapeutic Immunosuppression are Associated With Adverse Kidney Transplant Outcomes
por: Mendoza Rojas, Aleixandra, et al.
Publicado: (2022)

The Number of Donor-Specific IL-21 Producing Cells Before and After Transplantation Predicts Kidney Graft Rejection
por: van Besouw, Nicole M., et al.
Publicado: (2019)

The role of follicular T helper cells in the humoral alloimmune response after clinical organ transplantation
por: van Besouw, Nicole M., et al.
Publicado: (2019)

Adipose Tissue-Derived Mesenchymal Stem Cells Have a Heterogenic Cytokine Secretion Profile
por: Wu, Yongkang, et al.
Publicado: (2017)

Comparison of Alemtuzumab and Anti-thymocyte Globulin Treatment for Acute Kidney Allograft Rejection
por: van der Zwan, Marieke, et al.
Publicado: (2020)

Oxalate deposition in renal allograft biopsies within 3 months after transplantation is associated with allograft dysfunction
por: Snijders, Malou L. H., et al.
Publicado: (2019)

Immune Subsets From Ficoll Density Gradient Separation in Kidney Transplant Recipients
por: Udomkarnjananun, Suwasin, et al.
Publicado: (2022)

Circulating cell-free nucleosomes as biomarker for kidney transplant rejection: a pilot study
por: Verhoeven, Jeroen G. H. P., et al.
Publicado: (2021)

The Efficacy of Rabbit Anti-Thymocyte Globulin for Acute Kidney Transplant Rejection in Patients Using Calcineurin Inhibitor and Mycophenolate Mofetil-Based Immunosuppressive Therapy
por: van der Zwan, Marieke, et al.
Publicado: (2018)

Clinical and Molecular Profiling to Develop a Potential Prediction Model for the Response to Alemtuzumab Therapy for Acute Kidney Transplant Rejection
por: Hullegie‐Peelen, Daphne M., et al.
Publicado: (2022)

Belatacept Does Not Inhibit Follicular T Cell-Dependent B-Cell Differentiation in Kidney Transplantation
por: de Graav, Gretchen N., et al.
Publicado: (2017)

Tacrolimus intra-patient variability is not associated with chronic active antibody mediated rejection
por: Sablik, Kasia A., et al.
Publicado: (2018)

Mast Cells in Kidney Transplant Biopsies With Borderline T Cell-mediated Rejection and Their Relation to Chronicity
por: Varol, Hilal, et al.
Publicado: (2023)

Cholesterol Embolization Syndrome After Kidney Transplantation: A Case Series and Systematic Review
por: Francke, Marith I., et al.
Publicado: (2021)

Down-Regulation of Surface CD28 under Belatacept Treatment: An Escape Mechanism for Antigen-Reactive T-Cells
por: de Graav, Gretchen N., et al.
Publicado: (2016)

Characterization of donor and recipient CD8+ tissue-resident memory T cells in transplant nephrectomies
por: de Leur, Kitty, et al.
Publicado: (2019)

Differential T Cell Signaling Pathway Activation by Tacrolimus and Belatacept after Kidney Transplantation: Post Hoc Analysis of a Randomised-Controlled Trial
por: Kannegieter, Nynke M., et al.
Publicado: (2017)

Analysis of NFATc1 amplification in T cells for pharmacodynamic monitoring of tacrolimus in kidney transplant recipients
por: Kannegieter, Nynke M., et al.
Publicado: (2018)

Immunomics of Renal Allograft Acute T Cell-Mediated Rejection Biopsies of Tacrolimus- and Belatacept-Treated Patients
por: van der Zwan, Marieke, et al.
Publicado: (2018)

Boosting the VZV-Specific Memory B and T Cell Response to Prevent Herpes Zoster After Kidney Transplantation
por: Kho, Marcia M. L., et al.
Publicado: (2022)

The Effect of Tacrolimus and Mycophenolic Acid on CD14+ Monocyte Activation and Function
por: Kannegieter, Nynke M., et al.
Publicado: (2017)

Diagnostic Potential of Minimally Invasive Biomarkers: A Biopsy-centered Viewpoint From the Banff Minimally Invasive Diagnostics Working Group
por: Huang, Edmund, et al.
Publicado: (2022)

The Biological Effects of IL-21 Signaling on B-Cell-Mediated Responses in Organ Transplantation
por: Wu, Yongkang, et al.
Publicado: (2016)

Predicting Alloreactivity in Transplantation
por: Geneugelijk, Kirsten, et al.
Publicado: (2014)

A Decade of Experience With Alemtuzumab Therapy for Severe or Glucocorticoid-Resistant Kidney Transplant Rejection
por: van Vugt, Lukas K., et al.
Publicado: (2023)

Immune Cell Infiltrate in Chronic-Active Antibody-Mediated Rejection
por: Sablik, Kasia A., et al.
Publicado: (2020)

CD16+ Monocytes and Skewed Macrophage Polarization toward M2 Type Hallmark Heart Transplant Acute Cellular Rejection
por: van den Bosch, Thierry P. P., et al.
Publicado: (2017)

Review of the Clinical Pharmacokinetics and Pharmacodynamics of Alemtuzumab and Its Use in Kidney Transplantation
por: van der Zwan, Marieke, et al.
Publicado: (2017)

Avoiding Tacrolimus Underexposure and Overexposure with a Dosing Algorithm for Renal Transplant Recipients: A Single Arm Prospective Intervention Trial
por: Francke, Marith I., et al.
Publicado: (2021)

Alloreactivity-Based Medical Conditions
por: Vukmanovic, Stanislav, et al.
Publicado: (2013)

Metabolic Pathways in Alloreactive T Cells
por: Brown, Rebecca A., et al.
Publicado: (2020)

DNA-PKcs inhibitors sensitize neuroendocrine tumor cells to peptide receptor radionuclide therapy in vitro and in vivo
por: Reuvers, Thom G.A., et al.
Publicado: (2023)

The mast cell: A Janus in kidney transplants
por: van der Elst, G., et al.
Publicado: (2023)

Corrigendum: The mast cell: A Janus in kidney transplants
por: van der Elst, G., et al.
Publicado: (2023)

Activated CD4(+) T Cells and Highly Differentiated Alloreactive CD4(+) T Cells Distinguish Operationally Tolerant Liver Transplantation Recipients
por: Duizendstra, Aafke A., et al.
Publicado: (2021)

On the nature of peptides involved in T cell alloreactivity
Publicado: (1991)

Treatment with intravenous immunoglobulins and methylprednisolone may significantly decrease loss of renal function in chronic-active antibody-mediated rejection
por: Sablik, Kasia A., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_apkh868cc6h9u5he9da5oop8mg